EyePoint, Inc. SEC filings EYPT
EyePoint, Inc. has 1,001 filings in SEC EDGAR's recent list, going back to Jan 7, 2010. Its latest annual report, Form 10-K, was filed on Mar 5, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 5, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 19, 2026 (results of operations, exit or restructuring costs, other events). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| DEFA14A | Additional proxy material | Apr 27, 2026 | — |
| DEF 14A | Proxy statement | Apr 27, 2026 | Jun 18, 2026 |
| DEFA14A | Additional proxy material | May 9, 2025 | — |
| DEFA14A | Additional proxy material | Apr 28, 2025 | — |
| DEF 14A | Proxy statement | Apr 28, 2025 | Jun 18, 2025 |
| DEF 14A | Proxy statement | Apr 26, 2024 | Jun 20, 2024 |
| DEFA14A | Additional proxy material | Apr 26, 2024 | — |
| DEFA14A | Additional proxy material | Apr 28, 2023 | — |
| DEF 14A | Proxy statement | Apr 28, 2023 | Jun 20, 2023 |
| DEFA14A | Additional proxy material | Sep 28, 2022 | — |
| DEF 14A | Proxy statement | Sep 28, 2022 | Nov 10, 2022 |
| PRE 14A | Preliminary proxy statement | Sep 16, 2022 | Nov 10, 2022 |
| DEFA14A | Additional proxy material | Apr 28, 2022 | — |
| DEF 14A | Proxy statement | Apr 28, 2022 | Jun 23, 2022 |
| DEF 14A | Proxy statement | May 3, 2021 | Jun 22, 2021 |
| DEFA14A | Additional proxy material | Apr 30, 2021 | — |
| DEFA14A | Additional proxy material | Oct 16, 2020 | — |
| DEFA14A | Additional proxy material | Oct 16, 2020 | — |
| DEF 14A | Proxy statement | Oct 16, 2020 | Dec 1, 2020 |
| PRE 14A | Preliminary proxy statement | Oct 6, 2020 | Dec 1, 2020 |
| DEFA14A | Additional proxy material | Jun 4, 2020 | — |
| DEFA14A | Additional proxy material | Apr 28, 2020 | — |
| DEF 14A | Proxy statement | Apr 28, 2020 | Jun 23, 2020 |
| PRE 14A | Preliminary proxy statement | Apr 17, 2020 | Jun 23, 2020 |
| DEFA14A | Additional proxy material | Apr 29, 2019 | — |
| DEF 14A | Proxy statement | Apr 29, 2019 | Jun 25, 2019 |
| DEF 14A | Proxy statement | May 11, 2018 | Jun 22, 2018 |
| PRE 14A | Preliminary proxy statement | Apr 26, 2018 | Jun 22, 2018 |
| DEF 14A | Proxy statement | Nov 13, 2017 | Dec 15, 2017 |
| PRE 14A | Preliminary proxy statement | Nov 3, 2017 | Dec 15, 2017 |
| DEF 14A | Proxy statement | May 15, 2017 | Jun 27, 2017 |
| DEFA14A | Additional proxy material | May 4, 2017 | — |
| DEFA14A | Additional proxy material | May 4, 2017 | — |
| PRE 14A | Preliminary proxy statement | May 4, 2017 | Jun 27, 2017 |
| DEF 14A | Proxy statement | Oct 26, 2016 | Dec 12, 2016 |
| PRE 14A | Preliminary proxy statement | Oct 7, 2016 | Dec 12, 2016 |
| DEF 14A | Proxy statement | Oct 23, 2015 | Dec 3, 2015 |
| PRE 14A | Preliminary proxy statement | Sep 30, 2015 | Dec 3, 2015 |
| DEF 14A | Proxy statement | Oct 24, 2014 | Dec 11, 2014 |
| PRE 14A | Preliminary proxy statement | Oct 3, 2014 | Dec 11, 2014 |
| DEF 14A | Proxy statement | Oct 25, 2013 | Dec 18, 2013 |
| PRE 14A | Preliminary proxy statement | Oct 2, 2013 | Dec 18, 2013 |
| DEF 14A | Proxy statement | Oct 25, 2012 | Dec 14, 2012 |
| PRE 14A | Preliminary proxy statement | Oct 2, 2012 | Dec 14, 2012 |
| DEF 14A | Proxy statement | Oct 25, 2011 | Nov 29, 2011 |
| PRE 14A | Preliminary proxy statement | Sep 29, 2011 | Nov 29, 2011 |
| DEF 14A | Proxy statement | Oct 25, 2010 | Dec 9, 2010 |
| PRE 14A | Preliminary proxy statement | Oct 8, 2010 | Dec 9, 2010 |
Showing 48 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Laboratory Analytical Instruments (SIC 3826)
- Listed as
- EYPT (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Watertown, MA
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1314102
- Former names
- EyePoint Pharmaceuticals, Inc. (until Dec 8, 2025); pSivida Corp. (until Mar 30, 2018); pSivida LTD (until Jun 18, 2008)
Other Laboratory Analytical Instruments companies
- Agilent Technologies, Inc. A
- Waters Corp /DE/ WAT
- Illumina, Inc. ILMN
- Mettler Toledo International INC/ MTD
- Revvity, Inc. RVTY
- Avantor, Inc. AVTR
- Bio-Rad Laboratories, Inc. BIO
- Bruker Corp BRKR
Source: SEC EDGAR filings. This is company-reported data, not investment advice.